45.71MMarket Cap-2184P/E (TTM)
1.310High1.171Low61.34KVolume1.270Open1.200Pre Close77.05KTurnover0.27%Turnover RatioLossP/E (Static)35.16MShares55.00052wk High-19.12P/B29.52MFloat Cap1.17152wk Low--Dividend TTM22.71MShs Float55.000Historical High--Div YieldTTM11.63%Amplitude1.171Historical Low1.256Avg Price1Lot Size
FibroBiologics Stock Forum
The rest of stock continue to fall on a friday
FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology
FibroBiologics (Nasdaq: FBLG), a clinical-stage biotech company, has developed a novel artificial thymus organoid capable of restoring immune function in severe combined immunodeficiency (SCID) mouse models. This organoid is made from fibroblasts and thymus-derived cells and can produce mature and diverse T cells, including CD4, CD8, and regulatory T cells. The comp...
$BiomX (PHGE.US)$ $Larimar Therapeutics (LRMR.US)$ $Clene (CLNN.US)$ $Glucotrack (GCTK.US)$ $Sonnet BioTherapeutic (SONN.US)$ $FibroBiologics (FBLG.US)$ $NS WIND DOWN CO INC (NSTGQ.US)$
📊⚡️📊
No comment yet